Standout Papers

Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy 2014 2026 2018 2022 578
  1. Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy (2014)
    Steven L. Highfill, Yongzhi Cui et al. Science Translational Medicine

Immediate Impact

2 by Nobel laureates 22 from Science/Nature 84 standout
Sub-graph 1 of 19

Citing Papers

In vivo human T cell engineering with enveloped delivery vehicles
2024 StandoutNobel
CAR-T cell manufacturing: Major process parameters and next-generation strategies
2024 Standout
14 intermediate papers

Works of Steven L. Highfill being referenced

Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products
2022
Effects of starting cellular material composition on chimeric antigen receptor T‐cell expansion and characteristics
2019
and 8 more

Author Peers

Author Last Decade Papers Cites
Steven L. Highfill 1587 1678 692 83 2.8k
Shivani Srivastava 1798 1724 727 56 3.2k
Evelyn Ullrich 1842 2496 906 113 3.5k
Aurore Saudemont 1751 2010 685 55 3.0k
Thomas M. Schmitt 1760 2356 1427 50 3.9k
Ettore Biagi 1485 1363 652 74 2.7k
Jason Brayer 1133 1714 801 67 3.1k
Shadmehr Demehri 988 886 854 87 3.0k
Dirk Nagorsen 2592 2235 920 85 4.2k
Gundram Jung 1413 1642 856 113 2.9k
Hua Jiang 2309 1256 1140 81 3.4k

All Works

Loading papers...

Rankless by CCL
2026